Top Buy
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Faron Pharmaceuticals Oy | 3 | 0 | 0 | 0 | €2.88 | €10.00 | 247.826% |
| Gilead Sciences Inc | 11 | 1 | 0 | 0 | €61.20 | €84.81 | 38.582% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.74 | €4.00 | 45.985% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €41.80 | €50.00 | 19.617% |
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.87 | €5.51 | 531.684% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €90.20 | €100.00 | 10.865% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €2.94 | - | - |
| Geron Corp. | 12 | 0 | 0 | 0 | €3.19 | €4.63 | 44.964% |
| Xencor Inc. | 10 | 1 | 0 | 0 | €22.00 | €32.58 | 48.086% |
| Charles River Labs Intl | 10 | 0 | 0 | 0 | €199.20 | €248.57 | 24.784% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €19.31 | €26.01 | 34.678% |
| Anika Therapeutics | 5 | 0 | 0 | 0 | €23.60 | €28.29 | 19.876% |
| Corcept Therapeutics Inc. | 11 | 0 | 0 | 0 | €25.84 | €35.43 | 37.110% |
| Neurocrine Bioscience | 29 | 0 | 0 | 0 | €128.85 | €140.60 | 9.122% |
| AnaptysBio Inc | 8 | 1 | 0 | 0 | €23.20 | €45.21 | 94.871% |
| Sangamo Therapeutics Inc. | 12 | 12 | 0 | 0 | €0.58 | €3.63 | 526.805% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.99 | €8.35 | 320.161% |
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 0 | 0 | €1.48 | €5.34 | 259.811% |
| Immunogen Inc. | 5 | 0 | 0 | 0 | €28.97 | - | - |
| Cocrystal Pharma Inc. | 7 | 0 | 0 | 0 | €1.69 | €9.25 | 447.574% |
| Rigel Pharmaceutical Inc. | 10 | 0 | 0 | 0 | €0.82 | €13.77 | 1579.634% |
| Actinium Pharmaceuticals Inc. | 3 | 0 | 0 | 0 | €7.60 | €10.00 | 31.579% |
| Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €6.10 | €10.00 | 63.934% |